TL;DR
San Antonio is the third Texas biotech cluster (after Houston and DFW), anchored by UT Health San Antonio spinouts, the Texas Biomedical Research Institute, BioMed SA, and military medical research at Brooke Army Medical Center. The cluster operates under standard Texas surplus-lines placement with a federal contracting overlay distinctive to San Antonio - DoD and military medical research operators face contracting insurance requirements that commercial biotech programs do not address.
San Antonio biotech
San Antonio biotech insurance - UT Health SA, BioMed SA, Brooke Army Medical.
San Antonio is the third Texas biotech cluster, smaller than Houston (Texas Medical Center) and DFW but with a distinctive operator profile centered on UT Health San Antonio, the Texas Biomedical Research Institute, BioMed SA incubator infrastructure, and military medical research at Brooke Army Medical Center. The cluster operates under standard Texas surplus-lines placement with a federal contracting overlay distinctive to San Antonio.
Cluster characteristics
Academic biotech plus military medical research.
UT Health San Antonio contributes a clinical-stage biotech spinout pipeline across oncology, cardiovascular, and infectious disease programs. Insurance program follows standard clinical-stage architecture with attention to UT Health SA tech transfer office licensing terms.
Texas Biomedical Research Institute runs one of the largest US biocontainment research footprints (BSL-4 capability), with insurance demands distinctive to high-containment research operations.
BioMed SA incubator-stage operators run lean insurance programs at pre-IND stage, scaling as funding rounds close.
Brooke Army Medical Center and military medical research operators face federal contracting insurance requirements (Defense Base Act for non-US sites, specific bonding requirements, contract performance representations) that commercial biotech programs do not address.
Texas regulatory overlay
TDPSA, TDI, surplus-lines placement, federal contract overlay.
Texas operators follow the standard Texas surplus-lines placement architecture for biotech. The Texas Data Privacy and Security Act (TDPSA) effective July 2024 layers consumer-protection privacy obligations on top of HIPAA. Cyber liability programs should explicitly address TDPSA defense and notification expense.
For San Antonio operators with federal contracting activity, the contracting overlay produces specific insurance schedule demands that traditional commercial-only programs do not address. Defense Base Act coverage is required for any non-US trial sites or research operations under federal contract.
Premium levels for San Antonio biotech track at parity with Houston and DFW biotech equivalents on most lines, with federal-contracting specific lines priced individually.
San Antonio biotech coverage review